» Articles » PMID: 14740424

Laboratory Investigations Useful in Giant Cell Arteritis and Takayasu's Arteritis

Overview
Specialty Rheumatology
Date 2004 Jan 27
PMID 14740424
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

A raised erythrocyte sedimentation rate (ESR) is considered a hallmark for the diagnosis of giant cell arteritis (GCA). The American College of Rheumatology 1990 criteria for GCA include ESR greater than or equal to 50 mm/h as one of the five criteria. Although the presence of a normal ESR made GCA less likely, the results of a population-based study showed that the occurrence of a low/normal value in GCA at diagnosis is not rare. Pre-treatment ESR may be a prognostic indicator for duration of treatment. C-reactive protein (CRP) and interleukin-6 (IL-6) may be more sensitive indicators of disease activity than ESR in GCA patients. However, it is unclear whether the use in clinical practice of CRP and IL-6 has some apparent advantage over ESR. ESR is the most often used tool to assess disease activity in Takayasu's arteritis (TA). However, some studies have found that ESR and CRP are not able to differentiate patients with clinically active and inactive TA. Furthermore, histopathological studies have shown that over 40% of patients thought to be in clinical remission with normal acute phase reactants have active arteritis. IL-6 could be a promising marker of disease activity in TA; however, further studies are required to confirm its usefulness in clinical practice. Other laboratory investigations could be useful in the diagnosis or follow-up of GCA and TA, but more studies are required.

Citing Articles

Development of the Takayasu Arteritis Integrated Disease Activity Index.

Marvisi C, Bolek E, Ahlman M, Alessi H, Redmond C, Muratore F Arthritis Care Res (Hoboken). 2023; 76(4):531-540.

PMID: 38059340 PMC: 10963148. DOI: 10.1002/acr.25275.


Surgical intervention of Takayasu's arteritis with supraaortic arterial occlusive disease and critical ischemia of upper extremity: A case report.

Arslan C, Junusbekov Y, Hamid R SAGE Open Med Case Rep. 2023; 11:2050313X231205138.

PMID: 37829348 PMC: 10566259. DOI: 10.1177/2050313X231205138.


Leucine-rich alpha-2 glycoprotein as a potential biomarker for large vessel vasculitides.

Umezawa N, Mizoguchi F, Maejima Y, Kimura N, Hasegawa H, Hosoya T Front Med (Lausanne). 2023; 10:1153883.

PMID: 37215715 PMC: 10196172. DOI: 10.3389/fmed.2023.1153883.


Characteristics of Older Patients with Takayasu's Arteritis: A Two-Center, Cross-Sectional, Retrospective Cohort Study.

De Oliveira J, Dos Santos A, de Aguiar M, Goncalves Junior J, de Souza A, Pereira R Arq Bras Cardiol. 2023; 120(1):e20220463.

PMID: 36629607 PMC: 9833251. DOI: 10.36660/abc.20220463.


Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica.

Perricone C, Cafaro G, Fiumicelli E, Bursi R, Bogdanos D, Riccucci I Clin Exp Med. 2022; 23(7):3391-3397.

PMID: 36566303 DOI: 10.1007/s10238-022-00976-0.